Literature DB >> 11827633

Aortic valve sclerosis as a marker of active atherosclerosis.

Kelley R Branch1, Kevin D O'Brien, Catherine M Otto.   

Abstract

Aortic sclerosis is a calcific disease of the aortic valvular leaflets defined as focal leaflet thickening without significant obstruction to left ventricular outflow. Several clinical factors are associated with calcific aortic valve disease, including male sex, smoking, hypertension, age, hypercholesterolemia, and diabetes. Histologic and biochemical studies suggest similarities between the mechanisms involved in the development of aortic sclerosis and atherosclerosis, suggesting these two diseases may share common pathophysiologic mechanisms. In a recent prospective trial, the presence of aortic sclerosis was associated with an approximately 50% increase in cardiovascular mortality and myocardial infarction, even after correction for age, gender, known coronary artery disease, and clinical factors associated with a aortic sclerosis.

Entities:  

Mesh:

Year:  2002        PMID: 11827633     DOI: 10.1007/s11886-002-0022-8

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN: 1523-3782            Impact factor:   2.931


  37 in total

1.  Association of coronary risk factors with progression of valvular aortic stenosis in older persons.

Authors:  D Nassimiha; W S Aronow; C Ahn; M E Goldman
Journal:  Am J Cardiol       Date:  2001-06-01       Impact factor: 2.778

2.  Identification and characterization of calcifying valve cells from human and canine aortic valves.

Authors:  E R Mohler; M K Chawla; A W Chang; N Vyavahare; R J Levy; L Graham; F H Gannon
Journal:  J Heart Valve Dis       Date:  1999-05

3.  Effect of hydroxymethylglutaryl coenzyme a reductase inhibitors on the progression of calcific aortic stenosis.

Authors:  G M Novaro; I Y Tiong; G L Pearce; M S Lauer; D L Sprecher; B P Griffin
Journal:  Circulation       Date:  2001-10-30       Impact factor: 29.690

4.  Expression of HLA-DR antigen and smooth muscle cell differentiation markers by valvular fibroblasts in degenerative aortic stenosis.

Authors:  M Olsson; M Rosenqvist; J Nilsson
Journal:  J Am Coll Cardiol       Date:  1994-12       Impact factor: 24.094

5.  Presence of oxidized low density lipoprotein in nonrheumatic stenotic aortic valves.

Authors:  M Olsson; J Thyberg; J Nilsson
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-05       Impact factor: 8.311

6.  Apolipoproteins B, (a), and E accumulate in the morphologically early lesion of 'degenerative' valvular aortic stenosis.

Authors:  K D O'Brien; D D Reichenbach; S M Marcovina; J Kuusisto; C E Alpers; C M Otto
Journal:  Arterioscler Thromb Vasc Biol       Date:  1996-04       Impact factor: 8.311

7.  Accumulation of T lymphocytes and expression of interleukin-2 receptors in nonrheumatic stenotic aortic valves.

Authors:  M Olsson; C J Dalsgaard; A Haegerstrand; M Rosenqvist; L Rydén; J Nilsson
Journal:  J Am Coll Cardiol       Date:  1994-04       Impact factor: 24.094

8.  Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample.

Authors:  M Lindroos; M Kupari; J Heikkilä; R Tilvis
Journal:  J Am Coll Cardiol       Date:  1993-04       Impact factor: 24.094

9.  Factors associated with calcific aortic valve degeneration in the elderly.

Authors:  M Lindroos; M Kupari; J Valvanne; T Strandberg; J Heikkilä; R Tilvis
Journal:  Eur Heart J       Date:  1994-07       Impact factor: 29.983

10.  Inactivation of the osteopontin gene enhances vascular calcification of matrix Gla protein-deficient mice: evidence for osteopontin as an inducible inhibitor of vascular calcification in vivo.

Authors:  Mei Y Speer; Marc D McKee; Robert E Guldberg; Lucy Liaw; Hsueh-Ying Yang; Elyse Tung; Gerard Karsenty; Cecilia M Giachelli
Journal:  J Exp Med       Date:  2002-10-21       Impact factor: 14.307

View more
  7 in total

1.  Administration of angiotensin-converting enzyme inhibitors is associated with slow progression of mild aortic stenosis in Japanese patients.

Authors:  Kana Wakabayashi; Takeshi Tsujino; Yoshiro Naito; Akira Ezumi; Masaaki Lee-Kawabata; Shinji Nakao; Akiko Goda; Yasushi Sakata; Kazuhiro Yamamoto; Takashi Daimon; Tohru Masuyama
Journal:  Heart Vessels       Date:  2010-11-10       Impact factor: 2.037

2.  Adult aortic valve interstitial cells have greater responses to toll-like receptor 4 stimulation.

Authors:  Xin-Sheng Deng; Xianzhong Meng; QingChun Zeng; David Fullerton; Max Mitchell; James Jaggers
Journal:  Ann Thorac Surg       Date:  2014-10-22       Impact factor: 4.330

Review 3.  Genetic pathways of vascular calcification.

Authors:  Marion A Hofmann Bowman; Elizabeth M McNally
Journal:  Trends Cardiovasc Med       Date:  2012-05       Impact factor: 6.677

4.  Therapeutic vascular compliance change may cause significant variation in coronary perfusion: a numerical study.

Authors:  S Nobari; R Mongrain; E Gaillard; R Leask; R Cartier
Journal:  Comput Math Methods Med       Date:  2012-03-05       Impact factor: 2.238

Review 5.  Epidemiology and cardiovascular risk factors of aortic stenosis.

Authors:  Pompilio Faggiano; Francesco Antonini-Canterin; Ferdinando Baldessin; Roberto Lorusso; Antonio D'Aloia; Livio Dei Cas
Journal:  Cardiovasc Ultrasound       Date:  2006-07-01       Impact factor: 2.062

6.  Association of Aortic Valve Sclerosis with Previous Coronary Artery Disease and Risk Factors.

Authors:  Filipe Carvalho Marmelo; Sónia Matilde Fonseca Mateus; Alexandre José Marques Pereira
Journal:  Arq Bras Cardiol       Date:  2014-09-12       Impact factor: 2.000

Review 7.  Insights into aortic sclerosis and its relationship with coronary artery disease.

Authors:  Alexandra C Milin; Gabriel Vorobiof; Olcay Aksoy; Reza Ardehali
Journal:  J Am Heart Assoc       Date:  2014-09-05       Impact factor: 5.501

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.